In conclusion, the integrated proteomic workflow identified Dyrk2 SX and Dyrk2 RL as mutants with the strongest impact on the phosphorylation and interaction to CDPs suggesting a putative involvement of these mutants, possibly together with other factors, in cellular processes leading to cancer progression. Here, DYRK2 is linked to cancer.